| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Biol Chem, Vol. 273, Issue 14, 8033-8039, April 3, 1998
From the Neurobiotechnology Center and Departments of Biochemistry and Medical Biochemistry, The Ohio State University, Columbus, Ohio 43210
 |
ABSTRACT |
|---|
Top
Abstract
Introduction
Procedures
Results
Discussion
References
|
|---|
An open reading frame, ORF3, first identified adjacent to the mycocerosic acid synthase gene in Mycobacterium bovis BCG encodes a protein with acyl-CoA synthase (ACoAS) activity. Genes homologous to acoas are found adjacent to other multifunctional polyketide synthase genes in the mycobacterial genome. To test whether these gene products are necessary to esterify the fatty acids generated by the adjacent polyketide synthase gene products, the acoas gene was disrupted in M. bovis BCG using a suicide vector containing the acoas gene with an internal deletion and the hygromycin-resistant gene as selection marker. Allelic exchange at the acoas locus was confirmed by Southern hybridization and polymerase chain reaction amplification of both flanking regions expected from homologous recombination. Immunoblot analysis indicated that the 65-kDa ACoAS protein product was absent in the mutant. Chromatographic analysis of lipids derived from [1-14C]propionate showed that the mutant did not produce mycocerosyl lipids, although it produced normal levels of mycocerosic acid synthase. These results suggest that ACoAS is involved in the synthesis of mycocerosyl lipids of the mycobacterial cell wall.
| |
INTRODUCTION |
|---|
|
Top
Abstract
Introduction
Procedures
Results
Discussion
References
|
|---|
Tuberculosis is the leading cause of death from a single infectious agent, accounting for approximately 26% of all preventable adult deaths in the world. It is estimated that approximately 0.6 billion people are infected with the causative agent, Mycobacterium tuberculosis, with 8-10 million new cases and 3 million deaths occurring annually (1). Mycobacterial cell walls have a very high lipid content (50-60%), which constitutes an effective permeability barrier to antimycobacterial therapies and contributes to the survival of this pathogen within the host (2). In addition, conventional antimycobacterial treatments largely directed against cell wall lipids unique to pathogenic mycobacteria have been rendered less effective because of the increasing incidence of multidrug resistance. The increased incidence of tuberculosis associated with the AIDS pandemic has provided an added impetus to identify alternative targets that would allow for the development of novel therapeutic drugs (3, 4).
Other classes of cell wall lipids found solely in pathogenic mycobacteria include the phenolphthiocerols (mycosides) and the phthiocerols (5, 6) both of which have been reported to play a key role in the host-pathogen interaction (7, 8). In each of these lipid classes, multimethyl-branched long chain fatty acids, known as mycocerosic acids, are esterified to two long chain diols, the phenolphthiocerols and the phthiocerols, respectively (5, 8). This laboratory has previously cloned and characterized the mycocerosic acid synthase gene (mas) (9) and has identified a gene cluster involved in phthiocerol and phenolphthiocerol synthesis (pps) in Mycobacterium bovis BCG (10). In addition, we recently reported that a small open reading frame, ORF3, is located at the 5' end of the mas gene; amino acid sequence homology and enzyme assays using purified ORF3 protein indicated that this open reading frame encoded an ACoAS1 (11).
Genes homologous to acoas have been identified adjacent to the mas gene in M. tuberculosis (GenBankTM accession number Z83858) and Mycobacterium leprae (GenBankTM accession number U00010), as well as 5' to a polyketide synthase gene and 3' to a mas-like gene in M. tuberculosis (GenBankTM accession numbers Z74697, U00024, and Z77826). Given the high degree of homology among these genes (54-99% identity; 69-99% similarity), it seems likely that all these genes play a role in acyl transfer. The multiplicity and relative location of these genes adjacent to large polyketide synthase-like enzymes lead us to speculate that their gene products may be involved in the selective transfer of the acyl products of the neighboring synthase genes either directly or indirectly to the ultimate biological acceptors (11). Purified MAS fails to release mycocerosic acids, and mycocerosic acids are not found free in the cytosol but instead are esterified to the diols, which suggests the involvement of a separate transferase enzyme (12). A possible interaction of the mas and acoas gene products may be facilitated by their co-localization on the cell wall; immunogold labeling experiments indicate that MAS is associated with the cell membrane (13) and recent results also suggest that the ACoAS protein may be loosely bound to the membrane (11). However, in vitro studies indicated that purified ACoAS protein catalyzed the activation of mycocerosic acids to their corresponding thioesters only at extremely low rates. Furthermore, ACoAS failed to stimulate MAS activity and did not cause measurable release of mycocerosic acids either in the free form or as phthiocerol derivatives when phenolphthiocerol or glycosylated phenolphthiocerol was provided as acceptor (11). Although such in vitro reconstitution experiments failed to reveal the function of ACoAS, additional factors may be necessary for this protein to function in the transfer of mycocerosic acids to the diol acceptors.
The recent development and application of targeted gene disruption technology to slow growing mycobacterial species (10, 14-16) allowed us to directly test the in vivo function of ACoAS in M. bovis BCG. In this paper, we report the targeted disruption of the acoas gene in M. bovis BCG and show that this mutant is incapable of producing mycocerosyl lipids, although it has normal levels of mycocerosic acid synthase activity. These results suggest that acoas-like genes function in the transfer of acyl groups, generated by the products of adjacent polyketide synthase genes, to their ultimate biological acceptors.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
Top
Abstract
Introduction
Procedures
Results
Discussion
References
|
|---|
Bacterial Strains and Growth Conditions-- Strain descriptions and cultivation conditions for all the mycobacterial and Escherichia coli strains used in this study have been presented previously (11).
Generation of an acoas Gene Disruption Construct-- A pUC19-based plasmid, D2, which had previously been subcloned from a MAS-containing M. tuberculosis BCG cosmid (10), contained the entire 1.749-kb coding region of the acoas gene, 0.8-kb 5'-flanking region and 0.4-kb 3'-flanking region. A 181-base pair BglII fragment internal to the acoas gene was deleted and replaced with the hygromycin gene (hyg) from Streptomyces hygroscopicus. The hyg gene was excised as a 1.8-kb BglII fragment from plasmid pIJ963 (donated by Dr. John Hopwood, John Innes Center, Norwich, United Kingdom) and ligated with BglII digested D2, creating plasmid pORF3C35. The structure of this construct was verified by restriction enzyme digestion, Southern hybridization analysis, and sequencing of the ligation junctions.
Electroporation in M. bovis BCG-- Mid-log phase BCG cultures were subjected to glycine treatment and electroporated with 2 µg of XbaI digested pORF3C35 using previously outlined transformation parameters (17). Hygromycin-resistant transformants were selected on Middlebrook 7H11 plates (Difco) supplemented with oleic acid-albumin-dextrose complex (Difco) and hygromycin B (50 µg/ml) (Calbiochem) following incubation at 37 °C for 3-4 weeks.
Genomic DNA Isolation and Southern Blot Analysis--
High
molecular weight chromosomal DNA was isolated according to the method
of Jacobs et al. (17). DNA samples were digested with
appropriate restriction enzymes, transferred to nylon membranes (Nytran
Plus, Schleicher and Schuell), and hybridized with
[
-32P]dCTP-labeled probes according to standard
protocols (18).
PCR Analysis-- To screen hygromycin resistant M. bovis BCG transformants for homologous recombination, PCR amplification was performed directly on crude lysate of boiled cells. PCR amplification using standard protocols (Perkin Elmer) and Taq polymerase (Boehringer Mannheim) was performed using the following primer pairs: 5'-CGCGTTTAATAGCGCCCAGTCTAG-3' (A) and 5'-TTGAACTAGCGGCACGAAGAACAA-3' (B); 5'-CGGCGACGTCGTCAAGGAACCCAC-3' (C) and 5'GACACCGCCCCCGGCGCCTGACGC-3' (H1); 5' CGGCCAGCGTCCAAGAAAATACCG-3' (D) and 5'-TGGACCTCGACGACCTGCAGGCAT-3' (H2); 5'-TGATCCGACCGATGATGAAC-3' (E) and 5'-ACGGCGACAACGTCGGTAAT-3' (F).
Biochemical Analysis of Cell Wall Lipids in the Wild Type and ACoAS-disrupted M. bovis BCG Strains-- Na[1-14C]propionate (25 µCi, specific activity 55 Ci/mole) (American Radiolabeled Chemicals, MO) was added to 100 ml of 12-day-old cultures and incubation was continued at 37 °C in roller bottles for a further 18 h. Cell pellets, collected following centrifugation at 15,000 × g for 10 min, were extracted with an excess of chloroform:methanol (2:1) at room temperature. Total lipids were extracted by the Folch method (19) and assayed for 14C in Scintiverse BD using a Beckman LS3801 liquid scintillation spectrometer. Total lipids were separated on silica gel G plates (20 × 20-cm, 0.5-mm depth) using either chloroform:methanol (95:5) or n-hexane:ethyl ether (90:10) as solvent systems. Lipids were visualized by spraying chromatograms with 5% K2Cr2O7 in 50% sulfuric acid and heating at 180 °C for 10 min. 14C-Labeled lipids were detected by scanning chromatograms in a Berthold Tracemaster 20 TLC linear analyzer and by autoradiography. Silica gel containing labeled phenolphthiocerol and phthiocerol compounds was removed and lipid material eluted with ethyl ether. These lipids were refluxed with 5% KOH in 2-methoxyethanol containing 12% H2O for 3 h, the mixture was acidified with HCl, extracted with chloroform and the organic solvent was evaporated to dryness under reduced pressure. The residue was refluxed with 14% BF3 in methanol for 2 h and the products, recovered by chloroform extraction after quenching the reaction mixture with the addition of water, were subjected to thin-layer chromatography on silica gel G plates with n-hexane:diethyl ether (90:10) as the solvent. Methyl esters were extracted and analyzed by radio-gas chromatography using a Varian model 3300 gas chromatograph and a Lablogic GC-RAM radioactivity monitor (INUS Systems) operated under previously described parameters (16).
Extraction and Analysis of Total Proteins-- Cells from 500 ml of 12-day-old cultures of the wild type and acoas mutant strains were harvested by centrifugation, disrupted in a French press, and centrifuged at 105,000 × g for 90 min at 4 °C. Proteins present in the high speed supernatant were separated by SDS-PAGE on either a 3.5% stacking and 10% separating gel (ACoAS analysis) or a 3% stacking and 5% separating gel (MAS analysis) and protein bands were visualized by Coomassie Blue staining (20). For immunoblot analysis, electrophoresed proteins were transblotted onto an Immobilon polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA) as described previously (11). MAS and ACoAS antibodies were diluted 1:500 and 1:1000, respectively, and 125I-labeled protein A was used as the secondary detection reagent.
Determination of MAS and ACoAS Activities-- The cell-free extract was fractionated on a 1.8 × 12.5-cm DEAE-Sephadex (Sigma A25) column, and the column was washed with 2 bed volumes of 0.1 M potassium phosphate buffer, pH 6.8, containing 10% glycerol (v/v), 1 mM dithioerythritol, and 1 mM EDTA. Proteins were eluted with a 0.1-0.7 M potassium phosphate buffer gradient (5 bed volumes at a flow rate of 0.8 ml/min) and the MAS-containing fractions were identified by slot-blot analysis using the MAS specific antibody and the Supersignal ULTRA chemiluminescent detection system according to the manufacturer's recommendations (Pierce). MAS-containing fractions were pooled and concentrated by ultrafiltration using a PM30 membrane (Amicon, MA). MAS activity was quantified using labeled methylmalonyl-CoA as described previously (12), and activity is expressed as picomoles of methylmalonyl-CoA incorporated into hexane-extractable material per minute per milligram of protein. ACoAS activity was determined by quantifying the amount of fatty acyl-CoA in the aqueous phase following extraction of the reaction mixtures with organic solvents as described (21). ACoAS activity is expressed in units of fatty acyl-CoA formed per milligram of protein. One unit is defined as the amount of enzyme which forms 1 nmol of fatty acyl-CoA per minute. Protein concentrations were determined by the Bradford method (22) with bovine serum albumin as standard.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Procedures
Results
Discussion
References
|
|---|
Disruption of the acoas Gene by Allelic Exchange-- To examine the role of ACoAS in cell wall lipid metabolism, disruption of the acoas gene in M. bovis BCG was undertaken by allelic exchange. A pUC-based suicide plasmid, pORF3C35, was constructed containing the entire 1.749-kb acoas-coding region, 0.8-kb 5'-flanking region and 0.4-kb 3'-flanking region. An internal 181-base pair BglII fragment of acoas was replaced with a 1.8-kb hygromycin gene (hyg) as the selectable marker. Hygromycin-resistant transformants, generated with the linearized plasmid, were screened by PCR using a set of primers flanking the deleted internal segment of acoas (Fig. 1, primers A and B). This primer pair generates a single 0.7-kb PCR product from the wild type strain, 0.7-kb and 2.4-kb products in a mutant generated from a single crossover homologous recombination event, and a single 2.4-kb product in a mutant generated from double crossover homologous recombination. Analysis of approximately 500 hygromycin-resistant transformant colonies using this PCR screening strategy identified four mutants with single crossover events and two mutants with double crossover events. PCR amplification of representative single and double crossover mutants (RF3147 and RF320, respectively) using primers A and B is depicted in Fig. 2.
|
|
|
|
|
Immunological and Biochemical Characterization of the acoas Gene-disrupted Mutant-- When total proteins from the wild type and mutant RF320 were separated by SDS-PAGE and subjected to immunoblot analysis using an ACoAS specific antibody, the wild type showed a specific cross-reacting band of approximately 65 kDa, whereas this hybridizing band was not visible in the acoas-disrupted mutant (Fig. 6). This mutant expressed ACoAS activity at approximately 20% of wild type levels (0.17 units/mg protein versus 0.85 units/mg protein in the wild type) when 14C-labeled palmitic acid was used as the substrate. Therefore disruption of the acoas gene in mutant RF320 results in a failure to express a functional 65-kDa protein that encodes acyl-CoA synthase activity.
|
|
|
|
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Procedures
Results
Discussion
References
|
|---|
The process by which pathogenic mycobacteria transfer multimethyl-branched mycocerosic acids onto the diol acceptors on the cell wall is poorly understood. Previous results indicate that the M. bovis BCG mas gene lacks a chain-terminating thioesterase domain (9) and that mycocerosic acids remain attached to the synthase (12). Mycocerosic acids are found exclusively as esters of phenolphthiocerol and phthiocerol (7, 8), suggesting the involvement of a separate transferase system that mediates direct transfer of the newly synthesized mycocerosic acids from the synthase to the diol acceptors. Recently, we identified a small open reading frame at the 5' end of the mas gene, ORF3, which displays distinct homology to a number of ACoAS-like enzymes and purified ORF3 protein has ACoAS activity (11). However, we could not demonstrate the involvement of ACoAS in the in vitro activation of mycocerosic acids, mycocerosic acid release from MAS, or transfer of mycocerosyl groups from MAS to the diols (11). Therefore, we resorted to the in vivo disruption of acoas to determine the possible role played by this gene in mycocerosyl lipid synthesis. The recent successful application of allelic exchange technology to slow-growing mycobacterial species made such an approach feasible. To date, reciprocal recombination has been achieved using the mas gene (16), the pps gene cluster (10), and the ureC gene (14) in M. bovis BCG, and the leuD gene in M. tuberculosis (15). In the present study, the following evidence clearly showed that the M. bovis BCG acoas gene was disrupted by homologous recombination. Mutant RF320 lacks the internal segment deleted from the acoas gene, contains the hyg gene, and PCR amplification using a combination of hyg and flanking primers show that the disrupted allele has integrated into the correct region on the mycobacterial genome. Furthermore, the mutant fails to produce the 65-kDa protein encoded by acoas and has a drastically decreased ACoAS activity.
Disruption of the acoas gene in M. bovis BCG results in the production of a mutant that lacks the ability to produce mycosides and mycocerosyl phthiocerol esters. Radiolabeling studies with [1-14C]propionate, used to specifically label mycocerosic acids, show that even though mycocerosylated phenolphthiocerol esters are abundant in the wild type, this fraction is absent in the acoas disruptant. In addition, an examination of charred chromatograms confirms the total absence of mycoside production in the mutant. Radio-gas chromatography indicates that mycocerosic acids are significant components of the phthiocerol wax esters in the wild type strain. However, in the ACoAS disruptant mycocerosyl phthiocerols were not present; only shorter chain fatty acids were esterified to the phthiocerols.
Studies using the acoas mutant clearly show that this strain produces mycocerosic acid synthase. Partial purification of MAS by anion-exchange chromatography from the wild type and mutant strains yielded similar elution profiles. The purified proteins from both strains were discernible at similar levels following SDS-PAGE and immunoblot analysis, displayed comparable specific activities, and generated similar relative proportions of radiolabeled products from methylmalonyl-CoA. Therefore, it appears that while mycocerosic acid synthase is produced at wild type levels in the mutant, mycocerosic acids are not esterified onto the diol acceptors on the cell wall. This finding directly implicates ACoAS in the process by which mycocerosic acids are incorporated onto the diol acceptors in the cell wall of M. bovis BCG. With mandatory coupling of the synthesis and transfer, MAS would be unable to produce mycocerosic acids in the absence of a functional transfer mechanism. Alternatively, it is also possible that disruption of acoas affected the supply of the acyl-CoA primers required for the elongation of methylmalonyl-CoA by MAS and thus prevented mycocerosyl lipid synthesis. We consider this an unlikely possibility because highly homologous acoas genes are present near other polyketide synthase-like genes in the mycobacterial genome and these acoas genes are likely to encode acyl-CoA synthases that would have substituted for the disrupted one unless there is strict substrate specificity. Considering the composition of the long chain methyl-branched fatty acids present in the mycobacteria, C16, C18, and C20 primers would be adequate for the synthesis of all of these acids. If the acyl-CoA synthases encoded by the multiple acoas genes produce any of these primers, mycocerosic acids or their homologues would have been produced by the mutant as MAS is known to be able to use any of these primers (12). On the other hand it would appear more likely that the acoas products are specific for the transfer of the elongated acids generated by the synthases encoded by the gene adjacent to each acoas in the genome. Such a specificity may not only depend on the nature of the acyl chain but also on the interaction of this enzyme with a membrane bound partner that is probably involved in the acyl transfer to the final acceptor.
The observed lack of mycocerosyl lipids in the acoas disruptant is consistent with the participation of ACoAS in mycocerosyl transfer to the diols. Previous studies have shown that only mycocerosic acids are esterified to phenolphthiocerol and that shorter chain fatty acids cannot substitute in the acylation steps; a mas mutant that lacks the ability to synthesize mycocerosic acids also fails to generate any mycosides or mycocerosic acid-containing phthiocerols (16). Recent studies revealed that unlike MAS, a purified synthase that produces short chain branched acids releases its products directly as free fatty acids (23), which can then be esterified directly to the acceptors without requiring a separate ACoAS transfer system. Therefore, in the absence of a coupling of shorter chain branched fatty acid synthase and ACoAS transferase activities, disruption of ACoAS still permits synthesis of shorter chain fatty acids and their subsequent incorporation into the phthiocerol esters.
A possible explanation for the inability of ACoAS to cause mycocerosic acid transfer from MAS to the diols in vitro may be that this enzyme alone is not sufficient to effect transfer. In E. coli, ACoAS forms a transient membrane complex with a separate acyltransferase to promote the direct transfer of acyl moieties from enzyme bound fatty acyl-CoA to the transferase (24). At the C terminus of the mas gene, a short open reading frame has been identified which shares homology with polyketide synthase-type condensation enzymes that are involved in ester and amide bond synthesis (9, 25). This enzyme may function with ACoAS in transferring mycocerosic acids from MAS to the diols without involving release of free acids and activation of such released acids as discrete separate steps.
Genes displaying homology to the M. bovis BCG acoas gene have been identified adjacent to mas (GenBankTM accession number Z83858), mas-like genes (GenBankTM accession numbers Z77826 and Z97188) and polyketide synthase-like genes (GenBankTM accession numbers U00024, Z74697, and Z84725) in the M. tuberculosis genome. An acoas homologue is also present on the M. leprae genome adjacent to mas (GenBankTM accession number U00010). Overall, acoas-like genes located adjacent to polyketide synthases display 45-99% identity. Despite this high degree of conservation, acoas-like genes do not appear to be functionally interchangeable. We succeeded in creating a stable M. bovis BCG mutant with an altered pattern of lipid metabolism even though the other acoas-like genes were presumably intact in this mutant. The presence of additional acoas-like genes in the vicinity of large multifunctional polyketide synthases further supports our suggestion that the product of each acoas-like gene functions specifically with the products of the neighboring synthase gene to directly transfer their products to the appropriate acceptors on the mycobacterial cell wall.
Termination of a biosynthetic process, catalyzed by the product of a
multifunctional synthase gene, by a small protein encoded by an
adjacent open reading frame appears to be a commonly used mechanism not
only in the synthesis and assembly of complex polyketides but also in
the synthesis of other natural products. A coupling of multifunctional
synthase and transferase activities is believed to occur during
gramicidin biosynthesis; a thioesterase-like domain, located at the 5'
end of the gramicidin synthase gene and displaying homology to fatty
acid thioesterases, has been suggested to function as a transacylase in
the chain termination step (26, 27). Similar mechanisms also appear to
be involved in the synthesis of nonribosomal peptide synthases such as
-(L--aminoadipyl)-L-cysteinyl-D-valine synthase, which is involved in penicillin and cephalosporin
biosynthesis (28, 29) and the bialaphos antibiotic synthesizing gene
cluster (30). In mycobacteria each acoas-like gene, located
adjacent to each of the many multifunctional polyketide synthases,
probably functions at the terminal step to channel the product of the
synthase to the appropriate acceptor in the cell wall as demonstrated
in this paper for mycocerosyl lipid synthesis.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Linda Rogers and Norvin Fernandes for assistance with radio-gas chromatographic analysis.
| |
FOOTNOTES |
|---|
* This work was supported in part by Grant AI35272 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Neurobiotechnology
Center, Depts. of Biochemistry and Medical Biochemistry, The Ohio
State University, 206 Rightmire Hall, 1060 Carmack Rd., Columbus, OH 43210. Tel.: 614-292-5682; Fax: 614-292-5379; E-mail:
Kolattukudy.2{at}osu.edu.
1 The abbreviations used are: ACoAS, acyl-CoA synthase; PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis; kb, kilobase(s); MAS, mycocerosic acid synthase.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Procedures
Results
Discussion
References
|
|---|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Stadthagen, J. Kordulakova, R. Griffin, P. Constant, I. Bottova, N. Barilone, B. Gicquel, M. Daffe, and M. Jackson p-Hydroxybenzoic Acid Synthesis in Mycobacterium tuberculosis J. Biol. Chem., December 9, 2005; 280(49): 40699 - 40706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Hotter, B. J. Wards, P. Mouat, G. S. Besra, J. Gomes, M. Singh, S. Bassett, P. Kawakami, P. R. Wheeler, G. W. de Lisle, et al. Transposon Mutagenesis of Mb0100 at the ppe1-nrp Locus in Mycobacterium bovis Disrupts Phthiocerol Dimycocerosate (PDIM) and Glycosylphenol-PDIM Biosynthesis, Producing an Avirulent Strain with Vaccine Properties At Least Equal to Those of M. bovis BCG J. Bacteriol., April 1, 2005; 187(7): 2267 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Perez, P. Constant, F. Laval, A. Lemassu, M.-A. Laneelle, M. Daffe, and C. Guilhot Molecular Dissection of the Role of Two Methyltransferases in the Biosynthesis of Phenolglycolipids and Phthiocerol Dimycoserosate in the Mycobacterium tuberculosis Complex J. Biol. Chem., October 8, 2004; 279(41): 42584 - 42592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Onwueme, J. A. Ferreras, J. Buglino, C. D. Lima, and L. E. N. Quadri Mycobacterial polyketide-associated proteins are acyltransferases: Proof of principle with Mycobacterium tuberculosis PapA5 PNAS, March 30, 2004; 101(13): 4608 - 4613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Sirakova, V. S. Dubey, H.-J. Kim, M. H. Cynamon, and P. E. Kolattukudy The Largest Open Reading Frame (pks12) in the Mycobacterium tuberculosis Genome Is Involved in Pathogenesis and Dimycocerosyl Phthiocerol Synthesis Infect. Immun., July 1, 2003; 71(7): 3794 - 3801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rousseau, T. D. Sirakova, V. S. Dubey, Y. Bordat, P. E. Kolattukudy, B. Gicquel, and M. Jackson Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis Microbiology, July 1, 2003; 149(7): 1837 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Constant, E. Perez, W. Malaga, M.-A. Laneelle, O. Saurel, M. Daffe, and C. Guilhot Role of the pks15/1 Gene in the Biosynthesis of Phenolglycolipids in the Mycobacterium tuberculosis Complex. EVIDENCE THAT ALL STRAINS SYNTHESIZE GLYCOSYLATED p-HYDROXYBENZOIC METHYL ESTERS AND THAT STRAINS DEVOID OF PHENOLGLYCOLIPIDS HARBOR A FRAMESHIFT MUTATION IN THE pks15/1 GENE J. Biol. Chem., October 4, 2002; 277(41): 38148 - 38158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bardarov, S. Bardarov Jr, M. S. Pavelka Jr, V. Sambandamurthy, M. Larsen, J. Tufariello, J. Chan, G. Hatfull, and W. R. Jacobs Jr Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis Microbiology, October 1, 2002; 148(10): 3007 - 3017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Li, I. M. Monahan, S. J. Waddell, J. A. Mangan, S. L. Martin, M. J. Everett, and P. D. Butcher cDNA-RNA subtractive hybridization reveals increased expression of mycocerosic acid synthase in intracellular Mycobacterium bovis BCG Microbiology, August 1, 2001; 147(8): 2293 - 2305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kennedy, K. Auclair, S. G. Kendrew, C. Park, J. C. Vederas, and C. Richard Hutchinson Modulation of Polyketide Synthase Activity by Accessory Proteins During Lovastatin Biosynthesis Science, May 21, 1999; 284(5418): 1368 - 1372. [Abstract] [Full Text]
|
|
|
|
|
|
T. D. Sirakova, A. K. Thirumala, V. S. Dubey, H. Sprecher, and P. E. Kolattukudy The Mycobacterium tuberculosis pks2 Gene Encodes the Synthase for the Hepta- and Octamethyl-branched Fatty Acids Required for Sulfolipid Synthesis J. Biol. Chem., May 11, 2001; 276(20): 16833 - 16839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Camacho, P. Constant, C. Raynaud, M.-A. Laneelle, J. A. Triccas, B. Gicquel, M. Daffe, and C. Guilhot Analysis of the Phthiocerol Dimycocerosate Locus of Mycobacterium tuberculosis. EVIDENCE THAT THIS LIPID IS INVOLVED IN THE CELL WALL PERMEABILITY BARRIER J. Biol. Chem., June 1, 2001; 276(23): 19845 - 19854. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||
